These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15223095)
1. The effect of relapse on cognition in abstinent methamphetamine abusers. Simon SL; Dacey J; Glynn S; Rawson R; Ling W J Subst Abuse Treat; 2004 Jul; 27(1):59-66. PubMed ID: 15223095 [TBL] [Abstract][Full Text] [Related]
2. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence. Hester R; Lee N; Pennay A; Nielsen S; Ferris J Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923 [TBL] [Abstract][Full Text] [Related]
3. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995 [TBL] [Abstract][Full Text] [Related]
4. [A preliminary study on outpatient relapse prevention program for methamphetamine dependent patients: Serigaya Methamphetamine Relapse Prevention Program (SMARPP)]. Kobayashi O; Matsumoto T; Otsuki M; Endo K; Okudaira K; Harai H; Wada K Nihon Arukoru Yakubutsu Igakkai Zasshi; 2007 Oct; 42(5):507-21. PubMed ID: 18051470 [TBL] [Abstract][Full Text] [Related]
5. Corticolimbic dysregulation and chronic methamphetamine abuse. Baicy K; London ED Addiction; 2007 Apr; 102 Suppl 1():5-15. PubMed ID: 17493049 [TBL] [Abstract][Full Text] [Related]
6. It's the thought that counts: craving metacognitions and their role in abstinence from methamphetamine use. Lee NK; Pohlman S; Baker A; Ferris J; Kay-Lambkin F J Subst Abuse Treat; 2010 Apr; 38(3):245-50. PubMed ID: 20116959 [TBL] [Abstract][Full Text] [Related]
7. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960 [TBL] [Abstract][Full Text] [Related]
8. Changes in the episodic memory and executive functions of abstinent and relapsed alcoholics over a 6-month period. Pitel AL; Rivier J; Beaunieux H; Vabret F; Desgranges B; Eustache F Alcohol Clin Exp Res; 2009 Mar; 33(3):490-8. PubMed ID: 19120052 [TBL] [Abstract][Full Text] [Related]
9. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes. Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA; J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903 [TBL] [Abstract][Full Text] [Related]
10. Predictors of relapse in Filipino male methamphetamine users: a mixed methods approach. Tuliao AP; Liwag ME J Ethn Subst Abuse; 2011; 10(2):162-79. PubMed ID: 21678148 [TBL] [Abstract][Full Text] [Related]
11. Relapse antecedents for methamphetamine use and related factors in Taiwanese adolescents. Yen CF; Chang YP Psychiatry Clin Neurosci; 2005 Feb; 59(1):77-82. PubMed ID: 15679544 [TBL] [Abstract][Full Text] [Related]
12. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479 [TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes among women and men methamphetamine abusers in California. Hser YI; Evans E; Huang YC J Subst Abuse Treat; 2005 Jan; 28(1):77-85. PubMed ID: 15723735 [TBL] [Abstract][Full Text] [Related]
14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
15. Attentional control and brain metabolite levels in methamphetamine abusers. Salo R; Nordahl TE; Natsuaki Y; Leamon MH; Galloway GP; Waters C; Moore CD; Buonocore MH Biol Psychiatry; 2007 Jun; 61(11):1272-80. PubMed ID: 17097074 [TBL] [Abstract][Full Text] [Related]
16. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412 [TBL] [Abstract][Full Text] [Related]
18. Lack of longitudinal changes in cognition in individuals with methamphetamine use disorder during the first 6 weeks after commencing treatment. Fitzpatrick RE; Robinson AH; Rubenis AJ; Lubman DI; Verdejo-Garcia A Am J Drug Alcohol Abuse; 2021 May; 47(3):383-392. PubMed ID: 33524275 [No Abstract] [Full Text] [Related]
19. Do individuals with former amphetamine dependence have cognitive deficits? Rapeli P; Kivisaari R; Kähkönen S; Puuskari V; Autti T; Kalska H Nord J Psychiatry; 2005; 59(4):293-7. PubMed ID: 16195133 [TBL] [Abstract][Full Text] [Related]
20. Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence. Proebstl L; Krause D; Kamp F; Hager L; Manz K; Schacht-Jablonowsky M; Straif M; Riebschläger M; Neumann S; Schreiber A; Soyka M; Koller G Psychiatry Res; 2019 Nov; 281():112599. PubMed ID: 31629302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]